Evolent Health (EVH) Payables (2015 - 2026)

Evolent Health's Payables history runs 12 years deep, the most recent figure standing at $63.0 million for Q1 2026.

• In Q1 2026, Payables fell 72.56% year-over-year to $63.0 million; the TTM figure through Mar 2026 stood at $63.0 million (down 72.56% YoY), while the FY2025 annual figure was $59.8 million, down 77.65% from the prior year.
• Payables was $63.0 million for Q1 2026 at Evolent Health, up from $59.8 million in the prior quarter.
• In the past five years, Payables ranged from a high of $267.5 million in Q4 2024 to a low of $39.0 million in Q2 2024.
• Historically, Payables has averaged $94.9 million across 5 years, with a median of $63.0 million in 2026.
• Biggest YoY gain for Payables was 518.96% in 2025; the steepest drop was 77.65% in 2025.
• A 5-year view of Payables shows it stood at $57.2 million in 2022, then declined by 15.62% to $48.2 million in 2023, then jumped by 454.43% to $267.5 million in 2024, then sank by 77.65% to $59.8 million in 2025, then gained by 5.41% to $63.0 million in 2026.
• The last three Payables figures came in at $63.0 million (Q1 2026), $59.8 million (Q4 2025), and $77.3 million (Q3 2025), per Business Quant data.